A Phase I Study to Evaluate the Safety and Immunogenicity of Simultaneous Prime-Boost Immunisations With Candidate HCV and HIV-1 Vaccines, AdCh3NSmut1 / ChAdV63.HIVconsv and MVA-NSmut / MVA.HIVconsv, in Healthy Volunteers
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 08 May 2017
At a glance
- Drugs Hepatitis C vaccine (Primary) ; HIV vaccine (Primary)
- Indications Hepatitis C; HIV infections
- Focus Adverse reactions
- 02 May 2017 Planned End Date changed from 1 Oct 2016 to 1 Oct 2017.
- 02 May 2017 Status changed from recruiting to active, no longer recruiting.
- 20 Feb 2015 New trial record